279 related articles for article (PubMed ID: 18386709)
21. Gentamicin therapy in preterms: a comparison of two dosage regimens.
Krishnan L; George SA
Indian Pediatr; 1997 Dec; 34(12):1075-80. PubMed ID: 9715552
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
[TBL] [Abstract][Full Text] [Related]
23. High gentamicin trough concentrations in neonates of less than 28 weeks gestational age.
Zarowitz BJ; Wynn RJ; Buckwald S; Szefler SJ
Dev Pharmacol Ther; 1982; 5(1-2):68-75. PubMed ID: 7151639
[TBL] [Abstract][Full Text] [Related]
24. [Tolerability of once-daily-dosing of intravenous gentamicin in preterm neonates born at 32-37 weeks of gestation].
Miron D; Steinfeld M; Hasanein J; Felszer C; Reich D
Harefuah; 2003 Jun; 142(6):413-5, 487. PubMed ID: 12858823
[TBL] [Abstract][Full Text] [Related]
25. Extended-interval gentamicin administration in neonates: a simplified approach.
El-Chaar GM; Supaswud-Franks T; Venugopalan L; Kohn N; Castro-Alcaraz S
J Perinatol; 2016 Aug; 36(8):660-5. PubMed ID: 26986995
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.
Pullen J; Stolk LM; Nieman FH; Degraeuwe PL; van Tiel FH; Zimmermann LJ
Ther Drug Monit; 2006 Apr; 28(2):226-31. PubMed ID: 16628135
[TBL] [Abstract][Full Text] [Related]
27. Tolerability and outcomes of kinetically guided therapy with gentamicin in critically ill neonates during the first week of life: an open-label, prospective study.
Martínková J; Pokorná P; Záhora J; Chládek J; Vobruba V; Selke-Krulichová I; Chládková J
Clin Ther; 2010 Dec; 32(14):2400-14. PubMed ID: 21353108
[TBL] [Abstract][Full Text] [Related]
28. Gentamicin dosage recommendations for neonates based on half-life predictions from birthweight.
Charlton CK; Needelman H; Thomas RW; Kortas K
Am J Perinatol; 1986 Jan; 3(1):28-32. PubMed ID: 3942611
[TBL] [Abstract][Full Text] [Related]
29. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
[TBL] [Abstract][Full Text] [Related]
30. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels.
Hansen A; Forbes P; Arnold A; O'Rourke E
J Perinatol; 2003 Dec; 23(8):635-9. PubMed ID: 14647159
[TBL] [Abstract][Full Text] [Related]
31. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death.
Clark RH; Bloom BT; Spitzer AR; Gerstmann DR
Pediatrics; 2006 Jan; 117(1):67-74. PubMed ID: 16396862
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of a single daily dose of gentamicin in hospitalized Indian children: a quasi-randomized trial.
Tiwari S; Rehan HS; Chandra J; Mathur NN; Singh V
J Antimicrob Chemother; 2009 Nov; 64(5):1096-101. PubMed ID: 19759043
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
[TBL] [Abstract][Full Text] [Related]
35. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
van Maarseveen EM; Sprij A; Touw DJ
Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
[TBL] [Abstract][Full Text] [Related]
36. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of gentamicin dosing according to renal function in neonates with suspected sepsis.
Reimche LD; Rooney ME; Hindmarsh KW; Gorecki DK; Remillard AJ; Sankaran K
Am J Perinatol; 1987 Jul; 4(3):262-5. PubMed ID: 3606761
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of six extended-interval gentamicin dosing regimens in premature and full-term neonates.
Fullas F; Padomek MT; Thieman CJ; Van Gorp AE
Am J Health Syst Pharm; 2011 Jan; 68(1):52-6. PubMed ID: 21164066
[TBL] [Abstract][Full Text] [Related]
39. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
[TBL] [Abstract][Full Text] [Related]
40. Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease.
Moffett BS; Rossano JW
Ann Pharmacother; 2012 Sep; 46(9):1193-7. PubMed ID: 22911340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
